Company / Income Tax
Aligos Therapeutics, Inc. Income Tax History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$314.0K
FY2025
5-year range
$106.0K / $331.0K
FY2021-FY2025
Trend
-5.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax has fluctuated over the past 6 years, ranging from $85,000 in FY2020 to $331,000 in FY2024.
Based on SEC 10-K filings.
$314,000 in FY2025 with a 5-year CAGR of +29.9%.
Increased from $106,000 to $314,000 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- +30.0%
- 5-Year CAGR
- +29.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +29.9%, indicating consistent growth.
- In FY2025, income tax decreased 5.1% year-over-year.
- Peak income tax was recorded in FY2024.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $314.0K | -5.1% |
| FY2024 | $331.0K | +212.3% |
| FY2023 | $106.0K | -25.9% |
| FY2022 | $143.0K | -11.2% |
| FY2021 | $161.0K | +89.4% |
| FY2020 | $85.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026